BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that its common stock will be added to the S&P SmallCap 600 Index effective prior to the opening of trading on Monday, August 30, 2021.
https://finance.yahoo.com/news/biolife-solutions-joins-p-smallcap-151400131.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.